Status:
COMPLETED
Clinical Studies of Progeria
Lead Sponsor:
National Human Genome Research Institute (NHGRI)
Conditions:
Progeria
Eligibility:
All Genders
6-70 years
Brief Summary
This study will examine children with Hutchinson-Gilford Progeria syndrome, a genetic disease that causes many changes to the body over time, including heart disease, bone changes, hair loss, and join...
Detailed Description
Hutchison-Gilford Progeria Syndrome (HGPS) is a rare "premature aging" disease in which children die of severe atherosclerosis at an average age of thirteen years (range 8-20 years). Children with HGP...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Inclusion criteria consist of male and female children of all ethnic groups with the diagnosis of HGPS.
- An individual in whom a clinical diagnosis of HGPS has been
- verified by Dr. Gordon will be eligible for this protocol.
- EXCLUSION CRITERIA:
- \- Exclusion criteria consist of patients below 6 months and over 70 years of age. Another exclusion is the inability to travel to the NIH due to advanced cardiovascular disease, as reflected by unstable angina, congestive heart failure, or other serious symptoms.
Exclusion
Key Trial Info
Start Date :
October 14 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 22 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00094393
Start Date
October 14 2004
End Date
May 22 2018
Last Update
November 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892